These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 34243681)

  • 61. Salvianolic acid A preconditioning confers protection against concanavalin A-induced liver injury through SIRT1-mediated repression of p66shc in mice.
    Xu X; Hu Y; Zhai X; Lin M; Chen Z; Tian X; Zhang F; Gao D; Ma X; Lv L; Yao J
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):68-76. PubMed ID: 23993977
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ferulic acid attenuates non-alcoholic steatohepatitis by reducing oxidative stress and inflammation through inhibition of the ROCK/NF-κB signaling pathways.
    Wei Z; Xue Y; Xue Y; Cheng J; Lv G; Chu L; Ma Z; Guan S
    J Pharmacol Sci; 2021 Sep; 147(1):72-80. PubMed ID: 34294375
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Emodin worsens methionine-choline-deficient diet-induced non-alcoholic fatty liver disease in mice].
    Liu Q; Yu F; Yu N; Shi M; Wang F
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 May; 31(5):620-4. PubMed ID: 25940288
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor.
    Duan X; Meng Q; Wang C; Liu Z; Liu Q; Sun H; Sun P; Yang X; Huo X; Peng J; Liu K
    Phytomedicine; 2017 Feb; 25():83-92. PubMed ID: 28190475
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The improvement of nonalcoholic steatohepatitis by Poria cocos polysaccharides associated with gut microbiota and NF-κB/CCL3/CCR1 axis.
    Tan YY; Yue SR; Lu AP; Zhang L; Ji G; Liu BC; Wang RR
    Phytomedicine; 2022 Aug; 103():154208. PubMed ID: 35691078
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Protective effects of glycyrrhizic acid from edible botanical glycyrrhiza glabra against non-alcoholic steatohepatitis in mice.
    Wang C; Duan X; Sun X; Liu Z; Sun P; Yang X; Sun H; Liu K; Meng Q
    Food Funct; 2016 Sep; 7(9):3716-23. PubMed ID: 27487733
    [TBL] [Abstract][Full Text] [Related]  

  • 67. VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice.
    Velayudham A; Dolganiuc A; Ellis M; Petrasek J; Kodys K; Mandrekar P; Szabo G
    Hepatology; 2009 Mar; 49(3):989-97. PubMed ID: 19115316
    [TBL] [Abstract][Full Text] [Related]  

  • 68. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.
    Mridha AR; Wree A; Robertson AAB; Yeh MM; Johnson CD; Van Rooyen DM; Haczeyni F; Teoh NC; Savard C; Ioannou GN; Masters SL; Schroder K; Cooper MA; Feldstein AE; Farrell GC
    J Hepatol; 2017 May; 66(5):1037-1046. PubMed ID: 28167322
    [TBL] [Abstract][Full Text] [Related]  

  • 69. CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice.
    Chen G; Xu R; Zhang S; Wang Y; Wang P; Edin ML; Zeldin DC; Wang DW
    Am J Physiol Endocrinol Metab; 2015 Jan; 308(2):E97-E110. PubMed ID: 25389366
    [TBL] [Abstract][Full Text] [Related]  

  • 70. MicroRNA-29a Disrupts DNMT3b to Ameliorate Diet-Induced Non-Alcoholic Steatohepatitis in Mice.
    Yang YL; Kuo HC; Wang FS; Huang YH
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30917489
    [TBL] [Abstract][Full Text] [Related]  

  • 71. SCFAs alleviated steatosis and inflammation in mice with NASH induced by MCD.
    Deng M; Qu F; Chen L; Liu C; Zhang M; Ren F; Guo H; Zhang H; Ge S; Wu C; Zhao L
    J Endocrinol; 2020 Jun; 245(3):425-437. PubMed ID: 32302970
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The anti-inflammatory effect of Pien Tze Huang in non-alcoholic fatty liver disease.
    Lian B; Cai L; Zhang Z; Lin F; Li Z; Zhang XK; Jiang F
    Biomed Pharmacother; 2022 Jul; 151():113076. PubMed ID: 35550529
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet.
    Alshawsh MA; Alsalahi A; Alshehade SA; Saghir SAM; Ahmeda AF; Al Zarzour RH; Mahmoud AM
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164140
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Conophylline inhibits non-alcoholic steatohepatitis in mice.
    Nakade Y; Sakamoto K; Yamauchi T; Inoue T; Kobayashi Y; Yamamoto T; Ishii N; Ohashi T; Sumida Y; Ito K; Nakao H; Fukuzawa Y; Umezawa K; Yoneda M
    PLoS One; 2017; 12(6):e0178436. PubMed ID: 28594915
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Alternative pathway of bile acid biosynthesis contributes to ameliorate NASH after induction of NAMPT/NAD
    Yang N; Sun R; Zhang X; Wang J; Wang L; Zhu H; Yuan M; Xu Y; Ge C; He J; Wang M
    Biomed Pharmacother; 2023 Aug; 164():114987. PubMed ID: 37315437
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hepatic vagus nerve regulates Kupffer cell activation via α7 nicotinic acetylcholine receptor in nonalcoholic steatohepatitis.
    Nishio T; Taura K; Iwaisako K; Koyama Y; Tanabe K; Yamamoto G; Okuda Y; Ikeno Y; Yoshino K; Kasai Y; Okuno M; Seo S; Sakurai T; Asagiri M; Hatano E; Uemoto S
    J Gastroenterol; 2017 Aug; 52(8):965-976. PubMed ID: 28044208
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Protectin D1 inhibits TLR4 signaling pathway to alleviate non-alcoholic steatohepatitis via upregulating IRAK-M.
    Liu H; Li N; Kuang G; Gong X; Wang T; Hu J; Du H; Zhong M; Guo J; Xie Y; Xiang Y; Wu S; Yuan Y; Yin X; Wan J; Li K
    Free Radic Biol Med; 2024 Jan; 210():42-53. PubMed ID: 37984750
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Soyasaponin A
    Xiong F; Zheng Z; Xiao L; Su C; Chen J; Gu X; Tang J; Zhao Y; Luo H; Zha L
    Mol Nutr Food Res; 2021 Jul; 65(14):e2100067. PubMed ID: 34047448
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1.
    Zhang Y; Geng C; Liu X; Li M; Gao M; Liu X; Fang F; Chang Y
    Mol Metab; 2017 Jan; 6(1):138-147. PubMed ID: 28123944
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Shc inhibitor idebenone ameliorates liver injury and fibrosis in dietary NASH in mice.
    Jiang JX; Tomilov A; Montgomery C; Hui CK; Török NJ; Cortopassi G
    J Biochem Mol Toxicol; 2021 Oct; 35(10):e22876. PubMed ID: 34369032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.